Barclays’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $346K | Buy |
68,436
+37,114
| +118% | +$188K | ﹤0.01% | 3235 |
|
2025
Q1 | $177K | Sell |
31,322
-2,995
| -9% | -$16.9K | ﹤0.01% | 3406 |
|
2024
Q4 | $297K | Buy |
34,317
+5,629
| +20% | +$48.7K | ﹤0.01% | 3339 |
|
2024
Q3 | $199K | Buy |
28,688
+21,971
| +327% | +$152K | ﹤0.01% | 3478 |
|
2024
Q2 | $42K | Buy |
+6,717
| New | +$42K | ﹤0.01% | 3732 |
|